Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

3KGQ

Carboxypeptidase A liganded to an organic small-molecule: conformational changes

Summary for 3KGQ
Entry DOI10.2210/pdb3kgq/pdb
DescriptorCarboxypeptidase A1, ZINC ION, SODIUM ION, ... (8 entities in total)
Functional Keywordsintestinal protease, zinc-metallocarboxypeptidase-citrate ternary complex, carboxypeptidase, hydrolase, metal-binding, metalloprotease
Biological sourceBos taurus (bovine)
Cellular locationSecreted, extracellular space: P00730
Total number of polymer chains1
Total formula weight35823.05
Authors
Fernandez, D.,Boix, E.,Pallares, I.,Aviles, F.X.,Vendrell, J. (deposition date: 2009-10-29, release date: 2010-10-27, Last modification date: 2024-11-13)
Primary citationFernandez, D.,Boix, E.,Pallares, I.,Aviles, F.X.,Vendrell, J.
Structural and Functional Analysis of the Complex between Citrate and the Zinc Peptidase Carboxypeptidase A
Enzyme Res, 2011:128676-128676, 2011
Cited by
PubMed Abstract: A high-resolution carboxypeptidase-Zn(2+)-citrate complex was studied by X-ray diffraction and enzyme kinetics for the first time. The citrate molecule acts as a competitive inhibitor of this benchmark zinc-dependent peptidase, chelating the catalytic zinc ion in the active site of the enzyme and inducing a conformational change such that carboxypeptidase adopts the conformation expected to occur by substrate binding. Citrate adopts an extended conformation with half of the molecule facing the zinc ion, while the other half is docked in the S1' hydrophobic specificity pocket of the enzyme, in contrast with the binding mode expected for a substrate like phenylalanine or a peptidomimetic inhibitor like benzylsuccinic acid. Combined structural and enzymatic analysis describes the characteristics of the binding of this ligand that, acting against physiologically relevant zinc-dependent proteases, may serve as a general model in the design of new drug-protecting molecules for the oral delivery of drugs of peptide origin.
PubMed: 21804935
DOI: 10.4061/2011/128676
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.7 Å)
Structure validation

246704

PDB entries from 2025-12-24

PDB statisticsPDBj update infoContact PDBjnumon